ARTICLE | Company News
University of Oxford, Rogne Bioscience deal
September 1, 2014 7:00 AM UTC
The university’s Isis Innovation Ltd. tech transfer arm granted Rogne an exclusive, worldwide license to anti-inflammatory peptides. The deal includes C15, a peptide derived from chemerin that inhib...